Breaking News Instant updates and real-time market news.

ESRX

Express Scripts

$73.67

0.4 (0.55%)

, CI

Cigna

$177.14

1.1 (0.62%)

08:00
05/17/18
05/17
08:00
05/17/18
08:00

Express Scripts shares should be bought right here, says Baird

Baird analyst Eric Coldwell revisited his thesis on Express Scripts (ESRX) following results, the President's drug pricing proposals, and the recent proxy filing. Despite the White House blueprint not containing any immediate proposals, he believes the shares are unloved and under-owned and are about the same price today as they were before the Cigna (CI) announcement. Coldwell believes the shares should be bought regardless of the Cigna outcome, citing Express Scripts' consistent fundamental performance and improving business outlook. Coldwell reiterated his Outperform rating and $92 price target on Express Scripts shares.

ESRX

Express Scripts

$73.67

0.4 (0.55%)

CI

Cigna

$177.14

1.1 (0.62%)

  • 21

    May

  • 12

    Jun

ESRX Express Scripts
$73.67

0.4 (0.55%)

04/17/18
LEER
04/17/18
NO CHANGE
LEER
Amazon, Trump news positive for drug supply chain, distributors, says Leerink
Leerink analyst Ana Gupte sees the dual pronged news flow on Amazon (AMZN) being unlikely to enter the Hospital drug supply chain, and President Trump poised to give a speech on drug pricing and supply chain reform on April 26 as HHS Secretary Alex Azar solicits ideas for pricing reform as positive for both the drug supply chain across PBMs and drug distributors and biopharma manufacturers that have been roiled by fears of margin compression on both these threats. Within her coverage, the analyst views this as positive for UnitedHealth (UNH) with its Optum Rx PBM, Cigna (CI) with its deal to acquire Express Scripts (ESRX), and Aetna (AET) which has inked a deal with CVS (CVS) in part through equity, as well as Anthem (ANTM) with IngenioRx and Humana (HUM) with or without its potential Walmart (WMT) deal that has a sizable mail order operation.
05/01/18
PIPR
05/01/18
NO CHANGE
PIPR
Overweight
Piper says Regeneron deal with Express Scripts for Praluent 'looks meaningful'
Piper Jaffray analyst Christopher Raymond said Regeneron's (REGN) agreement with Express Scripts (ESRX) to improve Praluent access and make it the exclusive PCSK9 on the latter's preferred formulary may "set a somewhat dubious precedent," but he still sees it as a smart move that can reinvigorate Praluent growth. The analyst, who would expect similar agreements with other payers and PBMs are already in the works, keeps an Overweight rating on Regeneron shares.
05/03/18
LEER
05/03/18
NO CHANGE
Target $80
LEER
Market Perform
Express Scripts price target lowered to $80 from $90 at Leerink
Leerink analyst David Larsen lowered his price target for Express Scripts to $80 from $90 after the company reported mixed Q1 results and mostly reaffirmed prior 2018 guidance. The analyst reiterates a Market Perform rating on the shares.
05/03/18
PIPR
05/03/18
NO CHANGE
Target $450
PIPR
Overweight
Piper positive on Regeneron's 2018 set-up given Eylea strength, Praluent upside
Piper Jaffray analyst Christopher Raymond said he like the setup for Regeneron (REGN) for the rest of the year following the company's Q1 report. He thinks Eylea's strength can continue, Dupixent demand trends will remain healthy and that its recently announced Express Scripts (ESRX) deal can potentially reinvigorate Praluent and offers second half upside. Raymond maintains his Overweight rating on Regeneron, though he lowered his price target on the shares to $450 from $500 as he reduced his multiple given recent volatility in the space.
CI Cigna
$177.14

1.1 (0.62%)

03/13/18
BERN
03/13/18
INITIATION
Target $194
BERN
Market Perform
Cigna initiated with a Market Perform at Bernstein
Bernstein analyst Lance Wilkes initiated Cigna (CI) with a Market Perform rating and $195 price target following Cigna's announcement that it will buy Express Scripts (ESRX) for $67B. Wilkes views the deal as a bet that change comes more slowly to healthcare, and that financial returns from this deal will fund future strategic acquisitions for Cigna. In a research note to investors, Wilkes said he believes disruption is coming more quickly, in PBM and pharmacy and in the shift to value, and is "skeptical" of this move by Cigna. The analyst expects earnings growth to slow for Cigna driven by its employer focus, lack of scale and already best in class margins, and added that he has a "negative" outlook for Express Scripts, expecting declining gross margins as they lose Anthem (ANTM) and client pricing pressure as focus increases on drug costs.
03/15/18
DBAB
03/15/18
NO CHANGE
Target $236
DBAB
Buy
Cigna shares look oversold with or without deal, says Deutsche Bank
Cigna (CI) shares are down 26% from the January $226 high and 14% since the Express Scripts (ESRX) deal was announced on March 8, Deutsche Bank analyst Chris Rigg tells investors in a research note. The analyst estimates pro forma 2021 earnings per share of $21.18 for Cigna and Express Scripts. As such, he sees "ample conservatism" in management's 2021 EPS target range of $20-$21. With or without the deal, Cigna shares look oversold, Rigg contends. He keeps a Buy rating on Cigna with a $236 price target.
04/02/18
LEER
04/02/18
NO CHANGE
LEER
Possible Humana/Walmart deal transformational for U.S. seniors market, says Leerink
Leerink analyst Ana Gupte sees the possible Humana (HUM)-Walmart (WMT) deal as transformational for the U.S. Seniors market and estimates the deal value at close to $50B. The analyst also believes the deal helps Humana compete more effectively with UnitedHealth (UNH)/Optum and Aetna (AET)-CVS (CVS), while Walmart can also compete with Amazon (AMZN) that is eroding sales and likely eyeing an entry into the Prescription Rx market. Gupte expects the anti-trust scrutiny of three deals Aetna-CVS, Cigna (CI)-Express Scripts (ESRX) and Humana-Walmart by the DOJ will be more challenged under simultaneous review by the DOJ, though Walmart and Humana have the least anti-competitive issues. Humana-Walmart could catalyze a counter-offer for Cigna from Walgreens Boots Alliance (WBA) or even Amazon, or re-invigorate Walgreens-AmerisourceBergen (ABC) talks, she contends.

TODAY'S FREE FLY STORIES

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, ACIA

Acacia Communications

$33.68

1.49 (4.63%)

12:39
05/25/18
05/25
12:39
05/25/18
12:39
Periodicals
Trump administration says deal struck on ZTE Corp., NYT reports »

The Trump administration…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

ACIA

Acacia Communications

$33.68

1.49 (4.63%)

OCLR

Oclaro

$9.13

0.25 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 12

    Jun

  • 10

    Sep

NBR

Nabors Industries

$7.27

-0.54 (-6.91%)

12:35
05/25/18
05/25
12:35
05/25/18
12:35
Options
Nabors Industries put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$100.19

0.01 (0.01%)

12:31
05/25/18
05/25
12:31
05/25/18
12:31
Hot Stocks
PepsiCo confirms agreement to acquire Bare Snacks »

PepsiCo announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$100.29

0.11 (0.11%)

12:29
05/25/18
05/25
12:29
05/25/18
12:29
Periodicals
PepsiCo to acquire baked fruit and veggie snack maker Bare Foods, NYT reports »

PepsiCo will acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$55.19

0.41 (0.75%)

12:27
05/25/18
05/25
12:27
05/25/18
12:27
Periodicals
EEOC investigates age discrimination claims against Intel, WSJ reports »

The U.S. Equal Employment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$77.43

-5.52 (-6.65%)

12:20
05/25/18
05/25
12:20
05/25/18
12:20
Options
Notable ratio spread in Ross Stores as shares slump on earnings »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.45

-4.52 (-13.71%)

, FL

Foot Locker

$53.39

7.01 (15.11%)

12:18
05/25/18
05/25
12:18
05/25/18
12:18
General news
On The Fly: Top stock stories at midday »

The S&P 500 opened…

GPS

Gap

$28.45

-4.52 (-13.71%)

FL

Foot Locker

$53.39

7.01 (15.11%)

HLF

Herbalife Nutrition

$48.96

-4.89 (-9.08%)

IEP

Icahn Enterprises

$69.33

0.14 (0.20%)

FCAU

Fiat Chrysler

$21.86

-0.4 (-1.80%)

DGX

Quest Diagnostics

$106.60

5.71 (5.66%)

UNH

UnitedHealth

$244.87

2.14 (0.88%)

ROST

Ross Stores

$77.38

-5.57 (-6.71%)

ADSK

Autodesk

$132.89

-5.87 (-4.23%)

AAL

American Airlines

$45.31

1.76 (4.04%)

LUV

Southwest

$53.21

2 (3.91%)

DAL

Delta Air Lines

$55.80

1.39 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
05/25/18
05/25
12:17
05/25/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$162.03

-0.01 (-0.01%)

, DIA

Diamonds Fund ETF

$247.61

-0.29 (-0.12%)

12:16
05/25/18
05/25
12:16
05/25/18
12:16
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, fund flows…

IWM

iShares Trust Russell 2000 Index Fund

$162.03

-0.01 (-0.01%)

DIA

Diamonds Fund ETF

$247.61

-0.29 (-0.12%)

XLF

Financial Select Sector

$27.87

-0.08 (-0.29%)

XLE

Energy Select Sector SPDR

$74.03

-2.51 (-3.28%)

IVV

iShares Core S&P 500

$274.29

-0.46 (-0.17%)

SPY

SPDR S&P 500 ETF Trust

$272.41

-0.46 (-0.17%)

JNK

SPDR Barclays High Yield Bond

$35.72

-0.03 (-0.08%)

EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$109.63

0.28 (0.26%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.29

0.235 (0.20%)

EFV

iShares MSCI EAFE Value ETF

$54.37

-0.49 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
05/25/18
05/25
12:16
05/25/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$12.00

-1.04 (-7.98%)

12:15
05/25/18
05/25
12:15
05/25/18
12:15
Options
QEP Resources put volume heavy and directionally bearish »

Bearish flow noted in QEP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

AIPT

Precision Therapeutics

$1.00

0.01 (1.01%)

, SKLN

Ticker changed to AIPT

$0.00

(0.00%)

12:10
05/25/18
05/25
12:10
05/25/18
12:10
Hot Stocks
Skyline Medical says products approved on DAPA contract »

Skyline Medical sent the…

AIPT

Precision Therapeutics

$1.00

0.01 (1.01%)

SKLN

Ticker changed to AIPT

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$64.84

1.39 (2.19%)

12:05
05/25/18
05/25
12:05
05/25/18
12:05
Options
Kellogg call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

12:05
05/25/18
05/25
12:05
05/25/18
12:05
General news
Treasury Option Action: some bullish positioning »

Treasury Option Action:…

GIFI

Gulf Island Fabrication

$10.40

-0.05 (-0.48%)

11:56
05/25/18
05/25
11:56
05/25/18
11:56
Hot Stocks
Gulf Island Fabrication awarded 3300HP towboat newbuild project with option »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$102.96

0.86 (0.84%)

, TWX

Time Warner

$94.04

-0.22 (-0.23%)

11:54
05/25/18
05/25
11:54
05/25/18
11:54
Hot Stocks
Box Office Battle: 'Solo' looking to shoot first, take out 'Deadpool 2' »

Disney's (DIS) Han…

DIS

Disney

$102.96

0.86 (0.84%)

TWX

Time Warner

$94.04

-0.22 (-0.23%)

VIAB

Viacom

$27.69

0.4 (1.47%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$24.50

1.17 (5.02%)

LGF.B

Lionsgate

$23.05

1 (4.54%)

SNE

Sony

$46.56

0.11 (0.24%)

VIA

Viacom

$32.45

0.6 (1.88%)

FOX

21st Century Fox

$38.81

0.31 (0.81%)

FOXA

21st Century Fox

$39.25

0.32 (0.82%)

CMCSA

Comcast

$31.99

0.35 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$80.14

-0.44 (-0.55%)

11:53
05/25/18
05/25
11:53
05/25/18
11:53
Conference/Events
Nektar to hold 2018 ASCO Investor Event »

In conjunction with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

CELG

Celgene

$79.23

-0.25 (-0.31%)

11:50
05/25/18
05/25
11:50
05/25/18
11:50
Conference/Events
Celgene to hold analyst and investor event from ASCO Annual Meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 02

    Jun

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

NKE

Nike

$72.43

0.29 (0.40%)

11:50
05/25/18
05/25
11:50
05/25/18
11:50
Options
Notable spread in Nike as shares reach new highs »

Notable spread in Nike as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AFSI

AmTrust

$13.76

0.035 (0.26%)

11:49
05/25/18
05/25
11:49
05/25/18
11:49
Hot Stocks
Icahn says ISS recommends shareholders vote against AmTrust going-private deal »

Carl Icahn issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRLCY

L'Oreal

$0.00

(0.00%)

11:46
05/25/18
05/25
11:46
05/25/18
11:46
Hot Stocks
L'Oreal to acquire Pulp Riot Hair Color »

L'Oreal announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$38.70

2.72 (7.56%)

11:45
05/25/18
05/25
11:45
05/25/18
11:45
Options
Roku Inc (Class A Stock) call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
05/25/18
05/25
11:45
05/25/18
11:45
Conference/Events
Barclays biopharmaceutical analyst to hold an analyst/industry conference call »

U.S. Biopharmaceuticals…

PEG

PSEG

$52.59

0.66 (1.27%)

11:39
05/25/18
05/25
11:39
05/25/18
11:39
Conference/Events
PSEG to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$86.98

2.72 (3.23%)

11:33
05/25/18
05/25
11:33
05/25/18
11:33
Conference/Events
Molina Healthcare to host investor meeting »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.